Max Mitchell
Regional Managing Editor at The Legal Intelligencer
Regional Managing Editor at Law.com
Chief PA litigation reporter for @TheLegalIntel & @lawdotcom. Break news, analyze and investigate. Helplessly lost without spellcheck.
Articles
-
3 weeks ago |
tvmovie.de | Manny Hernandez |Max Mitchell
Gaming„Clair Obscur: Expedition 33“ im Test | Für diejenigen, die nach uns kommenDas Rollenspiel „Clair Obscur: Expedition 33“ will eine tiefgründige Geschichte mit rundenbasierten Kämpfen vermischen. Wieso das, trotz einiger Schwächen, außergewöhnlich funktioniert, erfahrt ihr im Test.
-
1 month ago |
law.com | Max Mitchell
It's that time of the year again where we ask you to submit firm data for our annual survey charting the headcount and financial metrics of the Garden State's top law firms. You can find the form to submit your information here. The deadline to submit the form is Tuesday, April 7, and it should take about five to ten minutes to complete. Results from the survey will be used for our New Jersey Top 40, Largest Law Firms and possibly other editorial projects this year.
-
1 month ago |
law.com | Colleen Murphy |Max Mitchell
White-collar attorneys in New Jersey were initially apprehensive about the decision to appoint Alina Habba, President Donald Trump's often fiery defender and councilor, as the new U.S. attorney for the Garden State, and statements the newly sworn-in top federal prosecutor has made in recent days have done little to reduce those fears.
-
1 month ago |
law.com | Max Mitchell
A Michigan attorney has lost his battle to enforce a fee-splitting agreement with a Pennsylvania attorney after the U.S. Court of Appeals for the Third Circuit determined the parties never entered into a contract. On Wednesday, a three-judge panel for the federal appeals court agreed to dismiss the lawsuit, Lento v.
-
1 month ago |
law.com | Max Mitchell
Two attorneys from Dechert have entered an appearance for GlaxoSmithKline in a securities class action that alleges the health care giant failed to properly disclose a 1982 report that showed the company's heartburn medication, Zantac, can break down into a carcinogenic compound. Takeaway: Claims about the alleged link between Zantac and cancer previously sparked personal injury litigation, with the company agreeing to pay up to $2.2 billion to settle 80,000 lawsuits last fall.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 1K
- Tweets
- 3K
- DMs Open
- No
RT @PhilaCourtsJury: Due to the global IT outage, the courts are closed today. If you were scheduled for jury duty today, you will be given…
Don't miss @Dellenware's story on how a Delaware judge's retirement from the Third Circuit could flip the political make-up of the court: https://t.co/JPfyUTckUw
Anyone interested in building out @lawdotcom's IP beat and helping to oversee @RecorderTweets - all from sunny California? You’ll be working with fun people, covering disputes between some of the largest companies in the world. If you’re interested we’d love to hear from you!